From: Validation of prognostic scores for survival in cancer patients beyond first-line therapy
Parameters | Number (Percentage) |
---|---|
Hemoglobin | |
Abnormal (< 11.5 g/dL for women; <13.0 g/dL for men) | 170 (58) |
Missing data | 4 |
Absolute neutrophil count | |
< 2000/μL | 16 (5) |
2000-7500/μL | 225 (76) |
> 7500/μL | 54 (18) |
Missing data | 4 |
Lymphocyte count | |
≤700/μL | 96 (32) |
700-1000/μL | 63 (21) |
≥1000/μL | 137 (46) |
Missing data | 3 |
Platelet count | |
< 130 G/L | 32 (11) |
130-400 G/L | 231 (78) |
> 400 G/L | 32 (11) |
Missing data | 4 |
Albumin | |
< 38 g/L | 172 (70) |
Missing data | 52 |
LDH | |
> 600 U/L | 89 (36) |
Missing data | 48 |
CRP | |
≤10 mg/L | 92 (41) |
10-50 mg/L | 79 (35) |
> 50 mg/L | 54 (24) |
Missing data | 74 |
IL-6 | |
> 8 pg/mL | 133 (48) |
Missing data | 21 |
VEGF | |
> 755 pg/mL | 66 (24) |
Missing data | 20 |